STAFFORD HOSPITAL
1. Target Overview & Investment Thesis
STAFFORD HOSPITAL is a 61-bed suburban community hospital in STAFFORD, VA with $127.9M in net patient revenue and a 5.7% operating margin. The hospital serves a payer mix of 26.7% Medicare, 3.0% Medicaid, and 70.3% commercial.
Thesis: Turnaround. Our ML models identify $9.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.7% to 13.0% (+736bps).
| Net Revenue HCRIS | $127.9M |
| Current EBITDA COMPUTED | $7.3M |
| Operating Margin COMPUTED | 5.7% |
| Occupancy HCRIS | 75.3% |
| Revenue / Bed COMPUTED | $2.1M |
| Net-to-Gross HCRIS | 39.3% |
| Distress Probability ML | 41.6% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 5.7% places it above the state median. Among 53 size-comparable peers (30-122 beds), the median margin is 6.1%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (30-122), prioritizing same-state peers. 53 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| STAFFORD HOSPITAL (Target) | VA | 61 | $127.9M | 5.7% |
| CARILION NEW RIVER VALLEY MED | VA | 94 | $261.3M | -0.5% |
| RICHMOND COMMUNITY HOSPITAL | VA | 96 | $254.9M | 21.5% |
| UVA HEALTH PRINCE WILLIAM MEDI | VA | 106 | $191.7M | -7.4% |
| JOHNSTON MEMORIAL HOSPITAL | VA | 100 | $188.3M | 6.1% |
| MARY IMMACULATE HOSPITAL | VA | 114 | $184.6M | 0.8% |
| LONESOME PINE HOSPITAL | VA | 56 | $175.6M | 17.2% |
| LEWISGALE HOSPITAL - MONTGOMER | VA | 92 | $155.7M | 40.7% |
| CULPEPER MEMORIAL HOSPITAL | VA | 70 | $153.9M | 9.3% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.6M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.5M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $82K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $7.3M |
| + RCM Uplift | +$9.4M |
| Pro Forma EBITDA | $16.7M |
| Current Margin | 5.7% |
| Pro Forma Margin | 13.0% |
| WC Released (1x) | $4.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $11.2M | $142.0M | 12.72x | 66.3% |
| Base (11x exit) | 10.0x | 11.0x | $11.2M | $159.8M | 14.32x | 70.3% |
| Bull Case | 9.0x | 11.0x | $10.0M | $194.5M | 19.36x | 80.9% |
| Bull (12x exit) | 9.0x | 12.0x | $10.0M | $215.2M | 21.42x | 84.6% |
| Bear Case | 11.0x | 10.0x | $12.3M | $91.3M | 7.44x | 49.4% |
| Bear (11x exit) | 11.0x | 11.0x | $12.3M | $104.4M | 8.50x | 53.4% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 53 hospitals with 30-122 beds
- Same-state prioritization (n=54)
- Comp margins: P25=-9.7% / P50=6.1% / P75=15.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.